GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ALR Technologies SG Ltd (OTCPK:ALRTF) » Definitions » 5-Year EBITDA Growth Rate

ALRTF (ALR Technologies SG) 5-Year EBITDA Growth Rate : 6.90% (As of Jun. 2023)


View and export this data going back to 1998. Start your Free Trial

What is ALR Technologies SG 5-Year EBITDA Growth Rate?

ALR Technologies SG's EBITDA per Share for the three months ended in Jun. 2023 was $-0.00.

During the past 3 years, the average EBITDA Per Share Growth Rate was 6.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 6.90% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -4.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of ALR Technologies SG was 35.90% per year. The lowest was -55.40% per year. And the median was 12.60% per year.


Competitive Comparison of ALR Technologies SG's 5-Year EBITDA Growth Rate

For the Medical Devices subindustry, ALR Technologies SG's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ALR Technologies SG's 5-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ALR Technologies SG's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where ALR Technologies SG's 5-Year EBITDA Growth Rate falls into.



ALR Technologies SG 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


ALR Technologies SG  (OTCPK:ALRTF) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


ALR Technologies SG 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of ALR Technologies SG's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


ALR Technologies SG Business Description

Traded in Other Exchanges
N/A
Address
7400 Beaufont Springs Drive, Suite 300, Richmond, VA, USA, 23225
ALR Technologies SG Ltd is a medical device company, which focuses on commercializing its Health-e-Connect System. It has developed a compliance monitoring system that will allow healthcare professionals to remotely monitor patient health conditions and provide patient health management. The company's Health-e-Connect Remote Diabetes Management Program is remote monitoring and care facilitation program that allows patients to upload their blood glucose data from their glucometers. Its geographical segments are the United States, which derives maximum revenue, Singapore, and Others.
Executives
Sidney Chan director, officer: CEO 7400 BEAUFONT SPRINGS DRIVE, SUITE 300, SUITE 300, RICHMOND VA 23225
Ronald Cheng director 255 SPRINGFIELD ROAD, OTTAWA A6 K1M 0K8
Peter H Stafford director 1-405 81ST STREET, OSOYOOS A1 V0H 1V2
William S Smith director, officer: Chief Commercial Officer 46 CHESTNUT HILL ROAD, WILTON CT 06897
Kenneth Robulak director 521 MANDALAY AVENUE, APT. 302, CLEARWATER FL 33767
Alfonso Salas director 2106 WEST 33RD AVENUE, VANCOUVER A1 V6M 1B9
Lawrence A Weinstein director, officer: President 13436 BLUE HEON LOOP, CHESTERFIELD VA 23838
Jaroslav V Tichy officer: Vice-President - Technologies 114M REYNOLDA VILLAGE, WINSTON-SALEM NC 27106
Stanley Cruitt director, 10 percent owner, officer: President 114M REYNOLDA VILLAGE, WINSTON-SALEM NC 27106